The World Health Organization announced on May 7 it will give emergency use authorization to the COVID-19 vaccine manufactured by China's Sinopharm.
The Chinese mainland on May 7 reported seven new COVID-19 cases, all of which were imported, the National Health Commission said in its daily report on May 8.
More than 297.7 million doses of COVID-19 vaccines had been administered across China as of Thursday, the National Health Commission said on May 7.
- NMPA Issues Announcement on Performing Consistency Evaluation of the Quality and Efficacy of Generic Chemical Injections
- NMPA Issues Guidance for On-Site Inspection of Independent Software Appended in Good Manufacturing Practice for Medical Devices
- NMPA Issues 5 Technical Review Guidances for the Registration of Tendon and Ligament Fixation Systems and Others